Registered Nurse in Yarmouth, ME Accepting Medicare

5 Registered Nurse nurses found. Showing 1 - 5

Danika Rencken, NP Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 2 Osterville Ct, Yarmouth, ME 04096 Phone: 603-732-2002

Nancy Keegan, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 297 Rogers Rd, Yarmouth, ME 04096 Phone: 207-846-0060

Dr. Susan Caplan, NP Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 55 Landing Woods, Yarmouth, ME 04096 Phone: 207-847-3400

Casey C Sanfilippo, APRN, FNP-BC Registered Nurse Medicare: Medicare Enrolled Practice Location: 259 Main St, Yarmouth, ME 04096 Phone: 207-846-9013

Kathleen C Montegut, APRN, CS Registered Nurse - Psych/Mental Health, Adult Medicare: Accepting Medicare Assignments Practice Location: 45 Forest Falls Dr, Ste B2, Yarmouth, ME 04096 Phone: 207-781-1588    Fax: 207-781-1543

News Archive

Fire rescue positioning system may be used to identify early-stage Parkinson's in older adults

A positioning system adapted for use in fire rescue operations will soon be tested on senior citizens in Sweden as a way to spot signs of early stage Parkinson's disease and other mobility problems.

PROTOX closes first tranche of investment by Warburg Pincus

Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today announced it has closed the first tranche of the investment by Warburg Pincus. The investment was approved by 100% of the votes cast by shareholders at the recent special shareholders meeting.

Instability and global food prices

In this report from the Center for Strategic & International Studies, part of its Global Forecast 2011, Johanna Nesseth Tuttle writes, "As food prices have risen - to a new, all-time high in 2011 - it is clear that, although we are not inevitably destined for instability as a result of declining food stocks, without serious commitment and focus we will be hard-pressed to manage the dramatic increase in food production that will be needed to meet global demand".

'Flurry' of new reports show wide variations on insurance rate costs

News outlets continue to follow recent studies released by several health policy groups about the expected premiums for plans offered on the new online insurance marketplaces.

Santarus, Pharming submit RHUCIN BLA to FDA for treatment of HAE attacks

Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) to obtain marketing approval for RHUCIN® (recombinant human C1 inhibitor) for the treatment of acute angioedema attacks in patients with Hereditary Angioedema (HAE).

Read more Medical News

› Verified 4 days ago